Corporate News     09-May-24
Lupin appoints Jeffrey Kindler and Alfonso Zulueta as Independent Directors on its Board
Lupin announced the appointment of Jeffrey Kindler and Alfonso “Chito” Zulueta as Independent Directors to its Board.

Kindler is an experienced healthcare executive, investor and advisor. He brings over four decades of business experience and has held leadership positions at some of the world's most recognized companies including Pfizer, where he served as Chairman & Chief Executive Officer, as well as McDonald's Corporation and General Electric Company. Before that, he was a partner at law firm Williams & Connolly.

Kindler is currently CEO of Centrexion Therapeutics, a privately held biotechnology company, Senior Advisor to Blackstone, Operating Partner at ARTIS Ventures and Global Chair of GLG Institute.

Zulueta spent over three decades in various roles of increasing responsibility with Eli Lilly and Company, including as Vice President of Global Marketing, President of Global Oncology and Critical Care Products and most recently, as President of International responsible for all geographies outside the United States and Canada. He also served as a corporate officer and member of Eli Lilly and Company's Executive Committee. Zulueta previously served as member of the board of the European Federation of Pharmaceutical Industries and Associations and the U.S.-Japan Business Council.

Zulueta currently serves as Non-Executive Chairman of the board of directors of Interpharma Investments Limited, the holding company of Zuellig Pharma, one of the largest healthcare services groups in Asia.

Previous News
  Lupin Nagpur unit clears USFDA inspection
 ( Hot Pursuit - 14-Jun-24   11:24 )
  Lupin's Nagpur facility successfully clears USFDA audit
 ( Corporate News - 14-Jun-24   10:25 )
  Lupin to transfer its trade generics biz in India to Lupin Life Sciences
 ( Corporate News - 08-Jun-24   14:09 )
  Lupin acquires Sanofi brands - Aarane™ and Nalcrom™
 ( Corporate News - 05-Jun-24   11:45 )
  Lupin Ltd up for third consecutive session
 ( Hot Pursuit - 22-May-24   13:05 )
  Lupin allots 1.22 lakh equity shares under ESOP
 ( Corporate News - 21-May-24   13:16 )
  Lupin’s USA facility gets 6 USFDA observations
 ( Hot Pursuit - 20-May-24   09:03 )
  Lupin achieves ISO 14001 and ISO 45001 certification
 ( Corporate News - 15-May-24   18:12 )
  Stock Alert: Indegene, Wipro, Biocon, HUDCO
 ( Market Commentary - Stock Alert 13-May-24   08:28 )
  Lupin grants 5,000 stock options under ESOP
 ( Corporate News - 10-May-24   17:55 )
  Lupin commences shipment of Mirabegron ER Tablets to US
 ( Corporate News - 10-May-24   17:51 )
Other Stories
  Yunik Managing Advisors to hold board meeting
  15-Jun-24   17:40
  Vasudhagama Enterprises to convene board meeting
  15-Jun-24   17:40
  Supreme Infrastructure India to convene board meeting
  15-Jun-24   17:40
  HCL Technologies to discuss results
  15-Jun-24   17:40
  Titagarh commences production of trainsets for Bangalore Metro
  15-Jun-24   14:06
  Blue Dart Express appoints Chief Commercial Officer
  15-Jun-24   14:01
  Automotive Stampings & Assemblies AGM scheduled
  15-Jun-24   13:56
  Galaxy Cloud Kitchens schedules EGM
  15-Jun-24   13:56
  Apollo Tyres to conduct AGM
  15-Jun-24   13:56
  Karnataka Bank launches KBL WISE Senior Citizen Savings Account
  15-Jun-24   13:56
Back Top